Bausch Health
BHC
#3590
Rank
C$4.20 B
Marketcap
$11.43
Share price
-0.12%
Change (1 day)
20.70%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$3.61

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.71. In 2022 the company made an earnings per share (EPS) of -$0.87 an increase over its 2021 EPS that were of -$3.71.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.61315.8%
2022-$0.87-76.64%
2021-$3.7168.45%
2020-$2.20-68.91%
2019-$7.09-57.11%
2018-$16.53-272.22%
2017$9.60-199.29%
2016-$9.67798.7%
2015-$1.08-128.31%
2014$3.80-204.62%
2013-$3.63602.7%
2012-$0.52-171.15%
2011$0.73-143.96%
2010-$1.65-206.57%
2009$1.55-11.2%
2008$1.752.46%
2007$1.70-7.58%
2006$1.84-14.29%
2005$2.1554%
2004$1.40-500%
2003-$0.35-141.67%
2002$0.84-4.76%
2001$0.88-175%
2000-$1.17-268%
1999$0.7014.94%
1998$0.6120.83%
1997$0.5053.83%
1996$0.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.40-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.38-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA